v3.26.1
Net (Loss) Income per Common Share - Schedule of Computation of the Numerator to Derive the Basic and Diluted Net (Loss) Income Per Common Share Amounts (Details) - USD ($)
$ in Thousands
12 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Mar. 31, 2024
Earnings Per Share [Abstract]      
(Loss) income from continuing operations, net of tax $ (397,907) $ (729,764) $ 4,546,353
Less: Loss from continuing operations, net of tax, attributable to noncontrolling interests (98,136) (184,598) (116,350)
(Loss) income from continuing operations, net of tax (299,771) (545,166) 4,662,703
Less: Earnings allocated to subsidiary potentially dilutive common stock equivalents 76,488 0 0
(Loss) income from continuing operations, net of tax, attributable to Roivant Sciences Ltd., diluted (376,259) (545,166) 4,662,703
Income (loss) from discontinued operations, net of tax 0 373,030 (315,147)
Less: Net loss from discontinued operations, net of tax attributable to noncontrolling interests 0 (155) (1,370)
Income (loss) from discontinued operations before income taxes attributable to Roivant Sciences Ltd. 0 373,185 (313,777)
Net (loss) income attributable to Roivant Sciences Ltd., basic (299,771) (171,981) 4,348,926
Net (loss) income attributable to Roivant Sciences Ltd., diluted $ (376,259) $ (171,981) $ 4,348,926